全新 FDA 指南 Project Optimus 可能如何影响肿瘤学临床试验和药物研究计划的未来

Julie Bullock, VP, global head of clinical pharmacology and translational medicine at Certara, discusses the FDA’s new guidance Project Optimus, which addresses issues relating to dose optimization in clinical trials assessing oncology drugs.